RA CAPITAL MANAGEMENT, L.P.

Insider Reports History

Location
Boston, MA
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by RA CAPITAL MANAGEMENT, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cytek Biosciences, Inc. Director, 10%+ Owner Common Stock 13,381,054 $127,120,013 $9.50 15 Mar 2022 Indirect
Wave Life Sciences Ltd. Director, 10%+ Owner Ordinary Shares 18,203,009 $121,732,622 $6.69 13 Nov 2025 Indirect
iTeos Therapeutics, Inc. Former 10% Owner Pre- Funded Warrants (Right to Buy) 6,614,285 $115,743,373 $17.50 12 May 2024 Indirect
Tyra Biosciences, Inc. Director, 10%+ Owner Common Stock 10,259,291 $103,926,617 $10.13 16 Jun 2025 Indirect
Fulcrum Therapeutics, Inc. 10%+ Owner Common Stock 6,053,960 $90,688,320 $14.98 08 Dec 2025 Indirect
Evommune, Inc. Director Common Stock 2,710,293 $75,562,968 $27.88 17 Feb 2026 Indirect
4D Molecular Therapeutics, Inc. 10%+ Owner Common Stock 4,563,211 $74,517,236 $16.33 09 Dec 2024 Indirect
Bicara Therapeutics Inc. Director, 10%+ Owner Common Stock 4,603,418 $73,654,688 $16.00 26 Feb 2026 Indirect
PepGen Inc. Director, 10%+ Owner Common Stock 18,554,273 $59,373,673 $3.20 26 Sep 2025 Indirect
Vor Biopharma Inc. Director, 10%+ Owner Common Stock 5,404,998 $58,428,028 $10.81 18 Dec 2025 Indirect
SpyGlass Pharma, Inc. Director, 10%+ Owner Common Stock 2,054,678 $57,181,689 $27.83 09 Feb 2026 Indirect
Vor Biopharma Inc. Director, 10%+ Owner Pre-Funded Warrant (Right to Buy) 10,000,000 $50,000,000 $5.00 18 Sep 2025 Indirect
Kala Pharmaceuticals, Inc. 10%+ Owner Common Stock 7,039,613 $47,446,992 $6.74 26 May 2022 Indirect
89bio, Inc. Director, 10%+ Owner Pre-Funded Warrants (Right to Buy) 0 $36,809,857 $8.50 30 Oct 2025 Indirect
Bicara Therapeutics Inc. Director, 10%+ Owner Pre-Funded Warrant (Right to Buy) 2,200,000 $35,199,780 $16.00 26 Feb 2026 Indirect
Enliven Therapeutics, Inc. Former 10% owner Common Stock 2,122,465 $32,123,508 $15.14 23 Feb 2023 Indirect
iTeos Therapeutics, Inc. Former 10% Owner Common Stock 2,545,510 $21,305,919 $8.37 12 May 2024 Indirect
Cidara Therapeutics, Inc. Director, 10%+ Owner Pre-Funded Warrants (Right to Buy) 0 $19,188,424 $14.91 07 Jan 2026 Indirect
Solid Biosciences Inc. 10%+ Owner Pre-Funded Warrants (Right to Buy) 3,722,085 $14,996,280 $4.03 19 Feb 2025 Indirect
Therapeutics Acquisition Corp. Director Common Stock 1,098,318 $13,674,059 $12.45 29 Jun 2021 Indirect
Tyra Biosciences, Inc. Director, 10%+ Owner Pre-Funded Warrants (Right to Buy) 1,000,000 $13,009,000 $13.01 18 Oct 2024 Indirect
Climb Bio, Inc. Director, 10%+ Owner Common Stock 3,403,429 $11,912,001 $3.50 05 Jan 2026 Indirect
RxSight, Inc. 10%+ Owner Common Stock 213,858 $10,265,312 $48.00 03 Aug 2021 Indirect
Black Diamond Therapeutics, Inc. Director Common Stock 3,213,828 $8,773,750 $2.73 05 Jul 2023 Indirect
Septerna, Inc. Director, 10%+ Owner Common Stock 1,471,943 $8,610,867 $5.85 28 Oct 2024 Indirect
Sionna Therapeutics, Inc. Director, 10%+ Owner Common Stock 159,033 $6,281,803 $39.50 21 Nov 2025 Indirect
Werewolf Therapeutics, Inc. Director, 10%+ Owner Common Stock 6,237,482 $6,112,732 $0.9800 14 May 2025 Indirect
Aerovate Therapeutics, Inc. 10%+ Owner Common Stock 1,287,858 $3,232,523 $2.51 28 Apr 2025 Indirect
AN2 Therapeutics, Inc. 10%+ Owner Common Stock 300,853 $324,921 $1.08 09 Aug 2024 Indirect
Mineralys Therapeutics, Inc. Director Common Stock 6,200 $212,536 $34.28 19 Feb 2026 Indirect
Aerovate Therapeutics, Inc. 10%+ Owner Stock Option (Right to Buy) 12,500 $204,625 $16.37 05 Jun 2024 Indirect
Janux Therapeutics, Inc. Director, 10%+ Owner Common Stock 6,250 $159,750 $25.56 11 Jun 2025 Indirect
Acumen Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 12,800 $14,080 $1.10 04 Jun 2025 Indirect
89bio, Inc. Director, 10%+ Owner Common Stock 0 $0 $14.70 30 Oct 2025 Indirect
Cidara Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 $0 $221.50 07 Jan 2026 Indirect
Cidara Therapeutics, Inc. Director, 10%+ Owner Series A Preferred Stock 0 $0 $15505.00 07 Jan 2026 Indirect
Icosavax, Inc. Director, 10%+ Owner Common Stock 0 $0 $15.29 19 Feb 2024 Indirect
Vor Biopharma Inc. Director, 10%+ Owner Warrant (Right to Buy) 21,121,449 30 Dec 2024 Indirect
Climb Bio, Inc. Director, 10%+ Owner Pre-Funded Warrants (Right to Buy) 20,440,000 11 Dec 2025 Indirect
4D Molecular Therapeutics, Inc. 10%+ Owner Pre-Funded Warrants (Right to Buy) 3,610,000 09 Dec 2024 Indirect
Artiva Biotherapeutics, Inc. Director, 10%+ Owner Common Stock 826,832 22 Jul 2024 Indirect
Boundless Bio, Inc. 10%+ Owner Common Stock 295,844 02 Apr 2024 Indirect
Wave Life Sciences Ltd. Director, 10%+ Owner Share Option (Right to Buy) 76,200 11 Aug 2025 Indirect
Nkarta, Inc. Director, 10%+ Owner Stock Option (right to buy) 46,000 05 Jun 2025 Indirect
Climb Bio, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 40,000 04 Jun 2025 Indirect
ARS Pharmaceuticals, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 30,000 25 Jun 2025 Indirect
SpyGlass Pharma, Inc. Director, 10%+ Owner Stock Option (right to buy) 27,400 05 Feb 2026 Indirect
Bicara Therapeutics Inc. Director, 10%+ Owner Stock Option (Right to Buy) 23,746 09 Jun 2025 Indirect
Tyra Biosciences, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 22,200 29 May 2025 Indirect
Acrivon Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 20,275 13 Jun 2025 Indirect
Sionna Therapeutics, Inc. Director, 10%+ Owner Non-Qualified Stock Option (right to buy) 19,959 12 Jun 2025 Indirect
Acumen Pharmaceuticals, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 19,500 04 Jun 2025 Indirect
Werewolf Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 17,500 24 May 2024 Indirect
Septerna, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 16,623 17 Jun 2025 Indirect
PepGen Inc. Director, 10%+ Owner Stock Option (Right to Buy) 16,000 04 Jun 2025 Indirect
Artiva Biotherapeutics, Inc. Director, 10%+ Owner Director Stock Option (Right to Buy) 13,750 24 Jun 2025 Indirect
LENZ Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 13,500 11 Jun 2025 Indirect
Janux Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 11,667 11 Jun 2025 Indirect
Mineralys Therapeutics, Inc. Director Stock Option (Right to Buy) 8,300 19 Feb 2026 Indirect
Vor Biopharma Inc. Director, 10%+ Owner Stock Option (Right to Buy) 3,000 18 Dec 2025 Indirect
89bio, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 0 30 Oct 2025 Indirect
Artiva Biotherapeutics, Inc. Director, 10%+ Owner Series A Preferred Stock 0 22 Jul 2024 Indirect
Artiva Biotherapeutics, Inc. Director, 10%+ Owner Series B Preferred Stock 0 22 Jul 2024 Indirect
Boundless Bio, Inc. 10%+ Owner Series B Preferred Stock 0 02 Apr 2024 Indirect
Boundless Bio, Inc. 10%+ Owner Series C Preferred Stock 0 02 Apr 2024 Indirect
Cidara Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 0 07 Jan 2026 Indirect
DICE Therapeutics, Inc. Former 10% owners and Director Common Stock 0 $46.50 09 Aug 2023 Indirect
DICE Therapeutics, Inc. Former 10% owners and Director Stock Option (Right to Buy) 0 09 Aug 2023 Indirect
Evommune, Inc. Director Series C Preferred Stock 0 07 Nov 2025 Indirect
Forma Therapeutics Holdings, Inc. Director, 10%+ Owner Common Stock 0 $5.05 14 Oct 2022 Indirect
Forma Therapeutics Holdings, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 0 14 Oct 2022 Indirect
Icosavax, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 0 19 Feb 2024 Indirect
Satsuma Pharmaceuticals, Inc. Former 10% Owner Common Stock 0 $0.9100 08 Jun 2023 Indirect
Satsuma Pharmaceuticals, Inc. Former 10% Owner Stock Option (Right to Buy) 0 08 Jun 2023 Indirect
Septerna, Inc. Director, 10%+ Owner Series B Preferred Stock 0 28 Oct 2024 Indirect
Sionna Therapeutics, Inc. Director, 10%+ Owner Series A Preferred Stock 0 10 Feb 2025 Indirect
Sionna Therapeutics, Inc. Director, 10%+ Owner Series B Preferred Stock 0 10 Feb 2025 Indirect
Sionna Therapeutics, Inc. Director, 10%+ Owner Series C Preferred Stock 0 10 Feb 2025 Indirect
Sionna Therapeutics, Inc. Director, 10%+ Owner Series Seed Preferred Stock 0 10 Feb 2025 Indirect
SpyGlass Pharma, Inc. Director, 10%+ Owner Series C-1 Preferred Stock 0 09 Feb 2026 Indirect
SpyGlass Pharma, Inc. Director, 10%+ Owner Series C-2 Preferred Stock 0 09 Feb 2026 Indirect
SpyGlass Pharma, Inc. Director, 10%+ Owner Series D Preferred Stock 0 09 Feb 2026 Indirect

Insider Reports Filed by RA CAPITAL MANAGEMENT, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCAX Bicara Therapeutics Inc. 26 Feb 2026 2 +$39,999,780 4 Director, 10%+ Owner 02 Mar 2026, 16:22
MLYS Mineralys Therapeutics, Inc. 19 Feb 2026 2 $0 4 Director 20 Feb 2026, 19:49
EVMN Evommune, Inc. 17 Feb 2026 1 +$1,000,000 4 Director 17 Feb 2026, 19:28
SGP SpyGlass Pharma, Inc. 09 Feb 2026 10 +$59,040,000 4 Director, 10%+ Owner 11 Feb 2026, 17:15
SGP SpyGlass Pharma, Inc. 05 Feb 2026 1 $0 4 Director, 10%+ Owner 09 Feb 2026, 17:05
SGP SpyGlass Pharma, Inc. 05 Feb 2026 0 $0 3 Director, 10%+ Owner 05 Feb 2026, 15:44
CDTX Cidara Therapeutics, Inc. 07 Jan 2026 6 -$2,425,254,095 4 Director, 10%+ Owner 09 Jan 2026, 17:13
CLYM Climb Bio, Inc. 05 Jan 2026 1 +$24,888 4 Director, 10%+ Owner 07 Jan 2026, 16:55
VOR Vor Biopharma Inc. 18 Dec 2025 2 -$49,999,990 4 Director, 10%+ Owner 19 Dec 2025, 18:58
CLYM Climb Bio, Inc. 11 Dec 2025 4 +$754,737 4 Director, 10%+ Owner 15 Dec 2025, 19:55
FULC Fulcrum Therapeutics, Inc. 08 Dec 2025 3 -$58,377,021 4 10%+ Owner 10 Dec 2025, 16:42
SION Sionna Therapeutics, Inc. 20 Nov 2025 12 -$1,200,704 4 Director, 10%+ Owner 24 Nov 2025, 17:43
SION Sionna Therapeutics, Inc. 17 Nov 2025 24 -$5,500,158 4 Director, 10%+ Owner 19 Nov 2025, 20:43
WVE Wave Life Sciences Ltd. 13 Nov 2025 1 +$6,688 4 Director, 10%+ Owner 14 Nov 2025, 18:14
/report/000134682425000049-ra-capital-management-l-p-2025-11-07 Evommune, Inc. 07 Nov 2025 6 +$20,000,000 4 Director, 10%+ Owner 12 Nov 2025, 16:26
/report/000123191925000435-ra-capital-management-l-p-2025-11-05 Evommune, Inc. 05 Nov 2025 0 $0 3 Director, 10%+ Owner 05 Nov 2025, 20:13
ETNB 89bio, Inc. 30 Oct 2025 10 $0 4 Director, 10%+ Owner 03 Nov 2025, 16:40
VOR Vor Biopharma Inc. 28 Oct 2025 4 -$10,368,938 4 Director, 10%+ Owner 30 Oct 2025, 18:40
SION Sionna Therapeutics, Inc. 24 Oct 2025 8 -$14,762,604 4 Director, 10%+ Owner 28 Oct 2025, 21:05
VOR Vor Biopharma Inc. 23 Oct 2025 3 -$6,204,863 4 Director, 10%+ Owner 27 Oct 2025, 20:04
VOR Vor Biopharma Inc. 20 Oct 2025 5 -$3,433,992 4 Director, 10%+ Owner 22 Oct 2025, 19:48
VOR Vor Biopharma Inc. 15 Oct 2025 16 -$13,707,361 4 Director, 10%+ Owner 17 Oct 2025, 18:03
PEPG PepGen Inc. 26 Sep 2025 1 +$30,000,000 4 Director, 10%+ Owner 30 Sep 2025, 16:35
VOR Vor Biopharma Inc. 18 Sep 2025 1 +$50,000,000 4 Director, 10%+ Owner 22 Sep 2025, 16:56
VOR Vor Biopharma Inc. 08 Sep 2025 1 $0 4 Director, 10%+ Owner 10 Sep 2025, 16:15
MLYS Mineralys Therapeutics, Inc. 04 Sep 2025 1 +$29,999,985 4 Director 08 Sep 2025, 17:59
WVE Wave Life Sciences Ltd. 11 Aug 2025 2 $0 4 Director, 10%+ Owner 13 Aug 2025, 20:10
CDTX Cidara Therapeutics, Inc. 26 Jun 2025 1 +$99,999,988 4 Director, 10%+ Owner 30 Jun 2025, 16:56
SPRY ARS Pharmaceuticals, Inc. 25 Jun 2025 1 $0 4 Director, 10%+ Owner 27 Jun 2025, 17:21
ARTV Artiva Biotherapeutics, Inc. 24 Jun 2025 1 $0 4 Director, 10%+ Owner 26 Jun 2025, 16:51
CDTX Cidara Therapeutics, Inc. 18 Jun 2025 1 $0 4 Director 18 Jun 2025, 17:20
SEPN Septerna, Inc. 17 Jun 2025 1 $0 4 Director, 10%+ Owner 20 Jun 2025, 18:46
ACRV Acrivon Therapeutics, Inc. 13 Jun 2025 1 $0 4 Director, 10%+ Owner 17 Jun 2025, 20:17
TYRA Tyra Biosciences, Inc. 12 Jun 2025 3 +$1,664,700 4 Director, 10%+ Owner 16 Jun 2025, 20:06
SION Sionna Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director, 10%+ Owner 16 Jun 2025, 17:15
JANX Janux Therapeutics, Inc. 11 Jun 2025 2 $0 4 Director, 10%+ Owner 13 Jun 2025, 19:33
LENZ LENZ Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director, 10%+ Owner 11 Jun 2025, 19:43
TYRA Tyra Biosciences, Inc. 09 Jun 2025 1 +$1,904,002 4 Director, 10%+ Owner 11 Jun 2025, 19:44
BCAX Bicara Therapeutics Inc. 09 Jun 2025 1 $0 4 Director, 10%+ Owner 10 Jun 2025, 16:34
NKTX Nkarta, Inc. 05 Jun 2025 1 $0 4 Director, 10%+ Owner 09 Jun 2025, 16:10
TYRA Tyra Biosciences, Inc. 04 Jun 2025 2 +$11,751,304 4 Director, 10%+ Owner 06 Jun 2025, 16:43
PEPG PepGen Inc. 04 Jun 2025 1 $0 4 Director, 10%+ Owner 06 Jun 2025, 08:43
ABOS Acumen Pharmaceuticals, Inc. 04 Jun 2025 2 $0 4 Director, 10%+ Owner 05 Jun 2025, 18:12
CLYM Climb Bio, Inc. 04 Jun 2025 1 $0 4 Director, 10%+ Owner 05 Jun 2025, 16:21
TYRA Tyra Biosciences, Inc. 29 May 2025 1 $0 4 Director, 10%+ Owner 02 Jun 2025, 16:16
VOR Vor Biopharma Inc. 22 May 2025 1 $0 4 Director, 10%+ Owner 23 May 2025, 17:47
HOWL Werewolf Therapeutics, Inc. 12 May 2025 3 +$487,188 4 Director, 10%+ Owner 14 May 2025, 18:08
JBIO Jade Biosciences, Inc. 28 Apr 2025 1 $0 4 10%+ Owner 30 Apr 2025, 16:52
MLYS Mineralys Therapeutics, Inc. 13 Mar 2025 1 +$17,499,996 4 Director 17 Mar 2025, 19:56
JANX Janux Therapeutics, Inc. 05 Mar 2025 4 +$25,342,965 4 Director, 10%+ Owner 07 Mar 2025, 18:05
SLDB Solid Biosciences Inc. 19 Feb 2025 1 +$14,996,280 4 10%+ Owner 21 Feb 2025, 16:11
MLYS Mineralys Therapeutics, Inc. 13 Feb 2025 1 $0 4 Director 24 Feb 2025, 21:41
SION Sionna Therapeutics, Inc. 10 Feb 2025 16 +$20,250,000 4 Director, 10%+ Owner 10 Feb 2025, 17:04
SION Sionna Therapeutics, Inc. 06 Feb 2025 0 $0 3 Director, 10%+ Owner 06 Feb 2025, 21:07
ETNB 89bio, Inc. 03 Feb 2025 1 $0 4 Director, 10%+ Owner 05 Feb 2025, 18:02
ETNB 89bio, Inc. 30 Jan 2025 1 +$49,999,994 4 Director, 10%+ Owner 03 Feb 2025, 17:38
CDTX Cidara Therapeutics, Inc. 03 Jan 2025 1 $0 4 Director 07 Jan 2025, 17:42
VOR Vor Biopharma Inc. 30 Dec 2024 2 $0 4 Director, 10%+ Owner 30 Dec 2024, 18:52
FDMT 4D Molecular Therapeutics, Inc. 09 Dec 2024 2 $0 4 10%+ Owner 10 Dec 2024, 16:28
CDTX Cidara Therapeutics, Inc. 26 Nov 2024 2 +$24,999,869 4 Director 29 Nov 2024, 16:15
ETNB 89bio, Inc. 14 Nov 2024 1 +$27,621,750 4 Director, 10%+ Owner 18 Nov 2024, 20:13
FDMT 4D Molecular Therapeutics, Inc. 13 Nov 2024 0 $0 3 10%+ Owner 25 Nov 2024, 16:33
TYRA Tyra Biosciences, Inc. 08 Nov 2024 1 +$19,836,066 4 Director, 10%+ Owner 13 Nov 2024, 17:00
SEPN Septerna, Inc. 28 Oct 2024 6 +$75,060,000 4 Director, 10%+ Owner 30 Oct 2024, 18:12
SEPN Septerna, Inc. 24 Oct 2024 0 $0 3 Director, 10%+ Owner 24 Oct 2024, 21:30
TYRA Tyra Biosciences, Inc. 18 Oct 2024 2 $0 4 Director, 10%+ Owner 22 Oct 2024, 17:04
JANX Janux Therapeutics, Inc. 18 Oct 2024 1 +$53,700,000 4 Director, 10%+ Owner 22 Oct 2024, 16:20
BCAX Bicara Therapeutics Inc. 16 Sep 2024 8 +$32,994,000 4 Director, 10%+ Owner 18 Sep 2024, 18:02
FULC Fulcrum Therapeutics, Inc. 12 Sep 2024 0 $0 3 10%+ Owner 23 Sep 2024, 16:15
BCAX Bicara Therapeutics Inc. 12 Sep 2024 1 $0 4 Director, 10%+ Owner 16 Sep 2024, 17:49
BCAX Bicara Therapeutics Inc. 12 Sep 2024 0 $0 3 Director, 10%+ Owner 12 Sep 2024, 21:27
FULC Fulcrum Therapeutics, Inc. 21 Aug 2024 2 $0 4 10%+ Owner 23 Aug 2024, 16:10
WVE Wave Life Sciences Ltd. 12 Aug 2024 2 $0 4 Director, 10%+ Owner 14 Aug 2024, 18:05
ANTX AN2 Therapeutics, Inc. 09 Aug 2024 2 -$3,807,102 4 10%+ Owner 13 Aug 2024, 17:03
ARTV Artiva Biotherapeutics, Inc. 22 Jul 2024 12 +$104,709,203 4 Director, 10%+ Owner 24 Jul 2024, 16:27
CDTX Cidara Therapeutics, Inc. 18 Jul 2024 3 +$100,000,000 4 Director 22 Jul 2024, 17:11
CDTX Cidara Therapeutics, Inc. 18 Jul 2024 1 $0 4/A Director 22 Jul 2024, 17:09
CDTX Cidara Therapeutics, Inc. 18 Jul 2024 1 $0 4 Director 19 Jul 2024, 17:16
ARTV Artiva Biotherapeutics, Inc. 18 Jul 2024 0 $0 3 Director, 10%+ Owner 18 Jul 2024, 20:08
CLYM Eliem Therapeutics, Inc. 27 Jun 2024 5 +$49,952,817 4 Director, 10%+ Owner 01 Jul 2024, 21:29
CLYM Eliem Therapeutics, Inc. 26 Jun 2024 1 $0 4 Director, 10%+ Owner 28 Jun 2024, 18:14
JANX Janux Therapeutics, Inc. 26 Jun 2024 2 $0 4 Director, 10%+ Owner 28 Jun 2024, 16:35
ACRV Acrivon Therapeutics, Inc. 20 Jun 2024 1 $0 4 Director, 10%+ Owner 24 Jun 2024, 17:36
SPRY ARS Pharmaceuticals, Inc. 20 Jun 2024 1 $0 4 Director, 10%+ Owner 24 Jun 2024, 17:13
PEPG PepGen Inc. 20 Jun 2024 1 $0 4 Director, 10%+ Owner 21 Jun 2024, 16:14
JBIO Aerovate Therapeutics, Inc. 17 Jun 2024 1 +$1,549,944 4 Director, 10%+ Owner 20 Jun 2024, 17:56
NKTX Nkarta, Inc. 13 Jun 2024 1 $0 4 Director, 10%+ Owner 14 Jun 2024, 16:18
ABOS Acumen Pharmaceuticals, Inc. 10 Jun 2024 1 $0 4 Director, 10%+ Owner 10 Jun 2024, 17:26
JBIO Aerovate Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director, 10%+ Owner 07 Jun 2024, 20:29
TYRA Tyra Biosciences, Inc. 29 May 2024 1 $0 4 Director, 10%+ Owner 31 May 2024, 18:26
HOWL Werewolf Therapeutics, Inc. 24 May 2024 1 $0 4 Director, 10%+ Owner 24 May 2024, 19:56
VOR Vor Biopharma Inc. 23 May 2024 1 $0 4 Director, 10%+ Owner 28 May 2024, 16:10
MLYS Mineralys Therapeutics, Inc. 22 May 2024 1 $0 4 Director 28 May 2024, 18:51
ITOS iTeos Therapeutics, Inc. 10 May 2024 3 +$99,994,273 4 Former 10% Owner 14 May 2024, 21:06
CDTX Cidara Therapeutics, Inc. 26 Apr 2024 1 $0 4 Director 30 Apr 2024, 16:37
CDTX Cidara Therapeutics, Inc. 24 Apr 2024 0 $0 3 Director 30 Apr 2024, 16:34
ACRV Acrivon Therapeutics, Inc. 11 Apr 2024 1 +$30,005,000 4 Director, 10%+ Owner 15 Apr 2024, 16:15
BOLD Boundless Bio, Inc. 02 Apr 2024 8 +$5,000,000 4 10%+ Owner 04 Apr 2024, 16:15
NKTX Nkarta, Inc. 27 Mar 2024 2 +$60,000,010 4 Director, 10%+ Owner 29 Mar 2024, 17:38
BOLD Boundless Bio, Inc. 27 Mar 2024 0 $0 3 10%+ Owner 27 Mar 2024, 20:16
SPRY ARS Pharmaceuticals, Inc. 25 Mar 2024 3 +$13,289,410 4 Director, 10%+ Owner 27 Mar 2024, 19:37
LENZ LENZ Therapeutics, Inc. 21 Mar 2024 9 +$15,000,075 4 Director, 10%+ Owner 25 Mar 2024, 20:48
LENZ LENZ Therapeutics, Inc. 21 Mar 2024 0 $0 3 Director 25 Mar 2024, 20:44
ETNB 89bio, Inc. 04 Mar 2024 1 +$20,722,500 4 Director, 10%+ Owner 06 Mar 2024, 17:40
JANX Janux Therapeutics, Inc. 04 Mar 2024 1 +$64,998,581 4 Director, 10%+ Owner 06 Mar 2024, 16:15
/report/000141588924004509-ra-capital-management-l-p-2024-02-19 Icosavax, Inc. 19 Feb 2024 5 $0 4 Director, 10%+ Owner 20 Feb 2024, 20:07
MLYS Mineralys Therapeutics, Inc. 12 Feb 2024 2 +$30,000,001 4 Director 14 Feb 2024, 19:49
PEPG PepGen Inc. 09 Feb 2024 1 +$27,212,790 4 Director, 10%+ Owner 13 Feb 2024, 16:33
TYRA Tyra Biosciences, Inc. 06 Feb 2024 2 +$61,387,604 4 Director, 10%+ Owner 08 Feb 2024, 17:16
SLDB Solid Biosciences Inc. 11 Jan 2024 1 +$5,000,005 4 Director, 10%+ Owner 12 Jan 2024, 17:01
WVE Wave Life Sciences Ltd. 11 Dec 2023 1 +$5,000,000 4/A Director, 10%+ Owner 17 Jan 2024, 19:06
WVE Wave Life Sciences Ltd. 11 Dec 2023 1 +$5,000,000 4 Director, 10%+ Owner 13 Dec 2023, 16:33
ETNB 89bio, Inc. 11 Dec 2023 1 +$9,998,918 4 Director, 10%+ Owner 13 Dec 2023, 16:31
SPRY ARS Pharmaceuticals, Inc. 21 Sep 2023 2 +$8,183,526 4 Director 25 Sep 2023, 16:30
SPRY ARS Pharmaceuticals, Inc. 29 Aug 2023 1 +$23,250,000 4 Director 31 Aug 2023, 17:26
ANTX AN2 Therapeutics, Inc. 18 Aug 2023 1 +$16,000,002 4 10%+ Owner 22 Aug 2023, 17:01
/report/000110465923089351-ra-capital-management-l-p-2023-08-09 DICE Therapeutics, Inc. 09 Aug 2023 3 $0 4 Former 10% owners and Director 09 Aug 2023, 17:00
WVE Wave Life Sciences Ltd. 07 Aug 2023 1 $0 4 Director, 10%+ Owner 09 Aug 2023, 20:00
ABOS Acumen Pharmaceuticals, Inc. 21 Jul 2023 1 +$39,999,998 4 Director, 10%+ Owner 25 Jul 2023, 16:30
JANX Janux Therapeutics, Inc. 19 Jul 2023 2 +$12,437,492 4 Director, 10%+ Owner 21 Jul 2023, 16:31
BDTX Black Diamond Therapeutics, Inc. 05 Jul 2023 1 +$4,679,250 4 Director 07 Jul 2023, 16:30
SPRY ARS Pharmaceuticals, Inc. 27 Jun 2023 1 $0 4 Director 28 Jun 2023, 21:00
HOWL Werewolf Therapeutics, Inc. 21 Jun 2023 1 $0 4 Director, 10%+ Owner 23 Jun 2023, 17:09
JANX Janux Therapeutics, Inc. 14 Jun 2023 1 $0 4 Director, 10%+ Owner 16 Jun 2023, 17:15
/report/000110465923070513-ra-capital-management-l-p-2023-06-08 Satsuma Pharmaceuticals, Inc. 08 Jun 2023 4 $0 4 Former 10% Owner 12 Jun 2023, 20:23
NKTX Nkarta, Inc. 07 Jun 2023 1 $0 4 Director, 10%+ Owner 09 Jun 2023, 16:30
ABOS Acumen Pharmaceuticals, Inc. 06 Jun 2023 1 $0 4 Director, 10%+ Owner 13 Jun 2023, 16:21
JBIO Aerovate Therapeutics, Inc. 06 Jun 2023 1 $0 4 Director, 10%+ Owner 08 Jun 2023, 18:00
SLDB Solid Biosciences Inc. 06 Jun 2023 1 $0 4 Director, 10%+ Owner 08 Jun 2023, 17:15
/report/000110465923069434-ra-capital-management-l-p-2023-06-06 Icosavax, Inc. 06 Jun 2023 1 $0 4 Director, 10%+ Owner 08 Jun 2023, 16:47
TYRA Tyra Biosciences, Inc. 31 May 2023 1 $0 4 Director, 10%+ Owner 02 Jun 2023, 16:31
VOR Vor Biopharma Inc. 26 May 2023 1 $0 4 Director, 10%+ Owner 02 Jun 2023, 18:09
CLYM Eliem Therapeutics, Inc. 18 May 2023 1 $0 4 Director, 10%+ Owner 22 May 2023, 17:22
/report/000110465923039250-ra-capital-management-l-p-2023-03-28 DICE Therapeutics, Inc. 28 Mar 2023 3 +$14,798,693 4 Director, 10%+ Owner 30 Mar 2023, 17:03
ETNB 89bio, Inc. 24 Mar 2023 1 +$39,999,992 4 Director, 10%+ Owner 30 Mar 2023, 17:00
/report/000110465923037172-ra-capital-management-l-p-2023-03-23 DICE Therapeutics, Inc. 23 Mar 2023 3 +$13,457,372 4 Director, 10%+ Owner 27 Mar 2023, 17:01
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 1 $0 4 Former 10% owner 27 Feb 2023, 15:31
MLYS Mineralys Therapeutics, Inc. 14 Feb 2023 6 +$20,000,000 4 Director 16 Feb 2023, 16:04
ETNB 89bio, Inc. 09 Feb 2023 4 +$7,499,996 4 Director, 10%+ Owner 15 Apr 2024, 16:15
MLYS Mineralys Therapeutics, Inc. 09 Feb 2023 1 $0 4 Director, 10%+ Owner 13 Feb 2023, 20:13
MLYS Mineralys Therapeutics, Inc. 09 Feb 2023 0 $0 3 Director, 10%+ Owner 09 Feb 2023, 19:06
FULC Fulcrum Therapeutics, Inc. 20 Jan 2023 1 +$24,999,988 4 10%+ Owner 24 Jan 2023, 15:30
HOWL Werewolf Therapeutics, Inc. 06 Jan 2023 1 +$4,095,130 4 Director, 10%+ Owner 10 Jan 2023, 16:14
FULC Fulcrum Therapeutics, Inc. 04 Jan 2023 2 +$1,314,806 4 10%+ Owner 06 Jan 2023, 15:39
ELVN IMARA Inc. 03 Jan 2023 1 +$2,516,055 4 10%+ Owner 05 Jan 2023, 15:43
FULC Fulcrum Therapeutics, Inc. 27 Dec 2022 1 +$24,510 4 10%+ Owner 29 Dec 2022, 16:00
FULC Fulcrum Therapeutics, Inc. 19 Dec 2022 1 +$582,814 4 10%+ Owner 21 Dec 2022, 15:30
FULC Fulcrum Therapeutics, Inc. 14 Dec 2022 3 +$13,073,874 4 10%+ Owner 16 Dec 2022, 15:41
SLDB Solid Biosciences Inc. 13 Dec 2022 1 $0 4 Director, 10%+ Owner 15 Dec 2022, 15:52
VOR Vor Biopharma Inc. 09 Dec 2022 1 +$50,000,000 4 Director, 10%+ Owner 09 Dec 2022, 15:32
ELVN IMARA Inc. 08 Dec 2022 2 +$115,595 4 10%+ Owner 12 Dec 2022, 15:30
SLDB Solid Biosciences Inc. 02 Dec 2022 3 +$15,249,996 4 Director, 10%+ Owner 05 Dec 2022, 16:02
ACRV Acrivon Therapeutics, Inc. 17 Nov 2022 5 +$42,368,750 4 Director, 10%+ Owner 21 Nov 2022, 15:31
ACRV Acrivon Therapeutics, Inc. 14 Nov 2022 1 $0 4 Director, 10%+ Owner 16 Nov 2022, 18:33
ACRV Acrivon Therapeutics, Inc. 09 Nov 2022 0 $0 3 Director, 10%+ Owner 09 Nov 2022, 19:30
SPRY ARS Pharmaceuticals, Inc. 08 Nov 2022 2 $0 4 Director 10 Nov 2022, 17:00
SPRY ARS Pharmaceuticals, Inc. 08 Nov 2022 0 $0 3 Director 10 Nov 2022, 16:00
ELVN IMARA Inc. 20 Oct 2022 3 +$336,812 4 10%+ Owner 24 Oct 2022, 16:41
ETNB 89bio, Inc. 18 Oct 2022 1 +$8,971,469 4 Director, 10%+ Owner 20 Oct 2022, 17:28
ELVN IMARA Inc. 17 Oct 2022 3 +$1,860,961 4 10%+ Owner 19 Oct 2022, 16:40
/report/000110465922110000-ra-capital-management-l-p-2022-10-17 DICE Therapeutics, Inc. 17 Oct 2022 1 +$59,860,000 4 Director, 10%+ Owner 19 Oct 2022, 16:32
ELVN IMARA Inc. 17 Oct 2022 0 $0 3 10%+ Owner 19 Oct 2022, 16:30
/report/000110465922108835-ra-capital-management-l-p-2022-10-14 Forma Therapeutics Holdings, Inc. 14 Oct 2022 6 $0 4 Director, 10%+ Owner 14 Oct 2022, 16:01
FULC Fulcrum Therapeutics, Inc. 16 Aug 2022 0 $0 3 10%+ Owner 26 Aug 2022, 16:39
WVE Wave Life Sciences Ltd. 15 Aug 2022 1 $0 4 Director, 10%+ Owner 17 Aug 2022, 20:01
ANTX AN2 Therapeutics, Inc. 03 Aug 2022 2 +$14,330 4 10%+ Owner 05 Aug 2022, 16:06
ANTX AN2 Therapeutics, Inc. 26 Jul 2022 2 +$180,675 4 10%+ Owner 28 Jul 2022, 17:16
ETNB 89bio, Inc. 01 Jul 2022 2 +$10,002,812 4 Director, 10%+ Owner 06 Jul 2022, 17:27
ANTX AN2 Therapeutics, Inc. 21 Jun 2022 1 +$2,413 4 10%+ Owner 23 Jun 2022, 16:31
JBIO Aerovate Therapeutics, Inc. 21 Jun 2022 1 $0 4 Director, 10%+ Owner 22 Jun 2022, 17:00
WVE Wave Life Sciences Ltd. 16 Jun 2022 2 +$35,632,763 4 Director, 10%+ Owner 21 Jun 2022, 16:33
ABOS Acumen Pharmaceuticals, Inc. 15 Jun 2022 1 $0 4 Director, 10%+ Owner 21 Jun 2022, 16:30
VOR Vor Biopharma Inc. 14 Jun 2022 1 $0 4 Director, 10%+ Owner 17 Jun 2022, 16:30
JANX Janux Therapeutics, Inc. 14 Jun 2022 1 $0 4 Director, 10%+ Owner 16 Jun 2022, 16:30
TYRA Tyra Biosciences, Inc. 13 Jun 2022 1 $0 4 Director, 10%+ Owner 15 Jun 2022, 16:30
ANTX AN2 Therapeutics, Inc. 13 Jun 2022 2 +$647,402 4 10%+ Owner 15 Jun 2022, 16:25
/report/000110465922071026-ra-capital-management-l-p-2022-06-10 Icosavax, Inc. 10 Jun 2022 2 $0 4 Director, 10%+ Owner 14 Jun 2022, 16:30
ITOS iTeos Therapeutics, Inc. 09 Jun 2022 1 $0 4 Director, 10%+ Owner 10 Jun 2022, 20:30
NKTX Nkarta, Inc. 08 Jun 2022 1 $0 4 Director, 10%+ Owner 10 Jun 2022, 21:07
/report/000110465922069745-ra-capital-management-l-p-2022-06-08 Forma Therapeutics Holdings, Inc. 08 Jun 2022 2 $0 4 Director, 10%+ Owner 09 Jun 2022, 17:30
SLDB Solid Biosciences Inc. 07 Jun 2022 1 $0 4 Director, 10%+ Owner 09 Jun 2022, 17:30
/report/000110465922069399-ra-capital-management-l-p-2022-06-07 DICE Therapeutics, Inc. 07 Jun 2022 1 $0 4 Director, 10%+ Owner 08 Jun 2022, 17:30
/report/000110465922069042-ra-capital-management-l-p-2022-06-03 Satsuma Pharmaceuticals, Inc. 03 Jun 2022 1 $0 4 Director, 10%+ Owner 07 Jun 2022, 17:31
HOWL Werewolf Therapeutics, Inc. 01 Jun 2022 1 $0 4 Director, 10%+ Owner 03 Jun 2022, 17:30
KALA Kala Pharmaceuticals, Inc. 26 May 2022 1 -$365,667 4 10%+ Owner 26 May 2022, 17:09
KALA Kala Pharmaceuticals, Inc. 23 May 2022 3 -$1,488,844 4 10%+ Owner 25 May 2022, 17:17
CLYM Eliem Therapeutics, Inc. 19 May 2022 1 $0 4 Director, 10%+ Owner 01 Jun 2022, 17:15
ETNB 89bio, Inc. 16 May 2022 1 $0 4 Director, 10%+ Owner 02 Jun 2022, 16:30
PEPG PepGen Inc. 10 May 2022 10 +$38,750,400 4 Director, 10%+ Owner 12 May 2022, 19:06
PEPG PepGen Inc. 06 May 2022 1 $0 4 Director, 10%+ Owner 10 May 2022, 16:31
PEPG PepGen Inc. 05 May 2022 0 $0 3/A Director, 10%+ Owner 12 May 2022, 18:50
ANTX AN2 Therapeutics, Inc. 29 Mar 2022 6 +$24,999,990 4 10%+ Owner 31 Mar 2022, 16:31
/report/000110465922040146-ra-capital-management-l-p-2022-03-28 Icosavax, Inc. 28 Mar 2022 2 +$836,883 4 Director, 10%+ Owner 30 Mar 2022, 16:31
ANTX AN2 Therapeutics, Inc. 24 Mar 2022 0 $0 3 10%+ Owner 24 Mar 2022, 21:22
CTKB Cytek Biosciences, Inc. 14 Mar 2022 2 +$7,188,926 4 Director, 10%+ Owner 16 Mar 2022, 17:10
CTKB Cytek Biosciences, Inc. 09 Mar 2022 3 +$8,158,671 4 Director 11 Mar 2022, 16:27
CTKB Cytek Biosciences, Inc. 04 Mar 2022 3 +$8,248,255 4 Director 08 Mar 2022, 15:59
CTKB Cytek Biosciences, Inc. 28 Feb 2022 3 +$5,721,951 4 Director 02 Mar 2022, 16:29
CTKB Cytek Biosciences, Inc. 23 Feb 2022 3 +$5,559,664 4 Director 25 Feb 2022, 16:43
CTKB Cytek Biosciences, Inc. 17 Feb 2022 3 +$7,695,707 4 Director 22 Feb 2022, 16:22
NKTX Nkarta, Inc. 14 Feb 2022 1 +$33,000,000 4 Director, 10%+ Owner 28 Apr 2022, 16:32
CTKB Cytek Biosciences, Inc. 14 Feb 2022 3 +$7,426,825 4 Director 16 Feb 2022, 18:39
/report/000110465921117369-ra-capital-management-l-p-2021-09-17 DICE Therapeutics, Inc. 17 Sep 2021 8 +$23,800,000 4 Director, 10%+ Owner 20 Sep 2021, 16:30
TYRA Tyra Biosciences, Inc. 17 Sep 2021 9 +$20,000,000 4 Director, 10%+ Owner 17 Sep 2021, 16:34
/report/000110465921115603-ra-capital-management-l-p-2021-09-14 DICE Therapeutics, Inc. 14 Sep 2021 0 $0 3 Director, 10%+ Owner 14 Sep 2021, 19:32
TYRA Tyra Biosciences, Inc. 14 Sep 2021 0 $0 3 Director, 10%+ Owner 14 Sep 2021, 19:11
WVE Wave Life Sciences Ltd. 16 Aug 2021 1 $0 4 Director, 10%+ Owner 18 Aug 2021, 17:32
CLYM Eliem Therapeutics, Inc. 12 Aug 2021 14 +$40,000,000 4 Director, 10%+ Owner 16 Aug 2021, 16:47
CLYM Eliem Therapeutics, Inc. 09 Aug 2021 1 $0 4 Director, 10%+ Owner 11 Aug 2021, 17:28
CLYM Eliem Therapeutics, Inc. 09 Aug 2021 0 $0 3 Director, 10%+ Owner 09 Aug 2021, 18:16
RXST RxSight, Inc. 03 Aug 2021 0 $0 3 10%+ Owner 13 Aug 2021, 16:33
/report/000110465921100106-ra-capital-management-l-p-2021-08-02 Icosavax, Inc. 02 Aug 2021 6 +$39,999,990 4 Director, 10%+ Owner 04 Aug 2021, 16:31
/report/000110465921097148-ra-capital-management-l-p-2021-07-28 Icosavax, Inc. 28 Jul 2021 0 $0 3 Director, 10%+ Owner 28 Jul 2021, 20:34
CTKB Cytek Biosciences, Inc. 27 Jul 2021 8 +$50,150,000 4 Director 29 Jul 2021, 16:30
CTKB Cytek BioSciences, Inc. 22 Jul 2021 0 $0 3 Director 22 Jul 2021, 21:24
ABOS Acumen Pharmaceuticals, Inc. 06 Jul 2021 8 +$30,000,000 4 Director, 10%+ Owner 08 Jul 2021, 16:32
JBIO Aerovate Therapeutics, Inc. 02 Jul 2021 8 +$38,999,996 4 Director, 10%+ Owner 06 Jul 2021, 17:03
ABOS Acumen Pharmaceuticals, Inc. 30 Jun 2021 0 $0 3 Director, 10%+ Owner 30 Jun 2021, 18:03
/report/000110465921087616-ra-capital-management-l-p-2021-06-29 Therapeutics Acquisition Corp. 29 Jun 2021 1 +$2,091,000 4 Director 30 Jun 2021, 16:30
JBIO Aerovate Therapeutics, Inc. 29 Jun 2021 0 $0 3 Director, 10%+ Owner 29 Jun 2021, 19:44
/report/000110465921085287-ra-capital-management-l-p-2021-06-23 Therapeutics Acquisition Corp. 23 Jun 2021 0 $0 3 Director 24 Jun 2021, 19:02
JANX Janux Therapeutics, Inc. 15 Jun 2021 10 +$49,999,992 4 Director, 10%+ Owner 16 Jun 2021, 17:21
HOWL Werewolf Therapeutics, Inc. 14 Jun 2021 3 +$4,129,398 4 Director, 10%+ Owner 16 Jun 2021, 16:58
JANX Janux Therapeutics, Inc. 10 Jun 2021 0 $0 3 Director, 10%+ Owner 10 Jun 2021, 19:05
ETNB 89bio, Inc. 02 Jun 2021 1 +$415,530 4 Director, 10%+ Owner 04 Jun 2021, 16:31
ETNB 89bio, Inc. 26 May 2021 3 +$3,857,063 4 Director, 10%+ Owner 28 May 2021, 18:41